NovaBridge Biosciences (NBP) Interest Expenses (2019)

NovaBridge Biosciences (NBP) has reported Interest Expenses for 8 consecutive years, with $253000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Interest Expenses rose 7.2% year-over-year to $253000.0; the TTM figure through Dec 2025 stood at $719000.0 (up 54.29% YoY), while the FY2025 annual figure was $76.4 million, up 36.32% from the prior year.
• Interest Expenses declined to $253000.0 in Q4 2025 per NBP's latest filing, from $19.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $136.7 million in Q4 2022 and bottomed at $230000.0 in Q3 2024.
• Historically, Interest Expenses has averaged $28.1 million across 5 years, with a median of $6.9 million in 2023.
• Annual changes were most pronounced in 2021 — Interest Expenses jumped 41331.48% — and 2024, when it tumbled 96.6%.
• NovaBridge Biosciences' Interest Expenses stood at $77.1 million in 2021, then soared by 77.17% to $136.7 million in 2022, then slumped by 94.92% to $6.9 million in 2023, then sank by 96.6% to $236000.0 in 2024, then increased by 7.2% to $253000.0 in 2025.
• Business Quant data shows NBP's Interest Expenses at $253000.0 in Q4 2025, $19.0 million in Q3 2025, and $4.6 million in Q2 2025.